Servier is a global pharmaceutical company focused on oncology and neurology, with research spanning cardiovascular diseases, cancers, diabetes, immune-inflammatory and neuropsychiatric diseases. The US arm communicates a commitment to science-driven therapeutics and patient care, supported by in-house research capabilities and a broad pipeline. It emphasizes partnerships, clinical development, and a patient-centric approach across its programs. Servier US highlights its leadership in oncology and neurology while addressing rare diseases and unmet medical needs.